课题基金 / 基金详情

TGF BETA RECEPTORS AND CELL PROLIFERATION

TGF BETA RECEPTORS AND CELL PROLIFERATION
TGFβ受体和细胞增殖
批准号:
6519742
负责人:
EDWARD B LEOF
金额:
$25.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-05-01 至 2003-04-30

项目摘要

项目成果

EDWARD B LEOF的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cellular proliferation is controlled by the integrated action of stimulatory and inhibitory growth factors. Transforming growth factor beta (TGF-beta) is unique in that regard since depending upon the cellular context it can either stimulate or inhibit cell growth. In general, mesenchymal-derived cells are growth stimulated while most other cell types are inhibited. It is presently unknown how 1 growth factor, binding to the same receptor species, can elicit such distinct phenotypes. The pivotal role which TGF-beta plays in modulating a number of biological activities makes it critical to identify potential targets through which TGF-beta actions are regulated. During the previous funding cycle we have determined that receptor endocytic activity is differentially modulated in mesenchymal and epithelial cell lines and that major determinants of TGF-beta receptor (TGF-betaR) internalization and signaling are the type II receptor kinase and a novel element in the type I receptor, respectively. We wish to extend these findings and test the general hypothesis that the cellular response to TGF-beta is controlled by the integrated activities of the endocytic and signaling machinery. This hypothesis will be addressed through a variety of approaches. First, we will characterize cellular proteins which regulate the initial membrane response to TGF- betaR oligomerization. Next, we will determine the function of a previously undefined element in the type I TGF-betaR in controlling downstream receptor signaling. Finally, we will identify mammalian TGF-beta signaling intermediaries using genetic analysis of yeast. Considering the importance of TGF- beta in various proliferative disorders, answers to these type of questions are critical if we hope to develop specific (and novel) intervention strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental Research Program
  • 批准号:
    10006089
  • 项目类别:
  • 资助金额:
    $9.06万
  • 财政年份:
    2018
  • 负责人:
    EDWARD B LEOF
  • 依托单位:
CAF, A COACTIVATOR OF FOS, AND BREAST CANCER
  • 批准号:
    6124492
  • 项目类别:
  • 资助金额:
    $20.45万
  • 财政年份:
    1997
  • 负责人:
    EDWARD B LEOF
  • 依托单位:
TGF BETA RECEPTOR DYNAMICS
  • 批准号:
    2024368
  • 项目类别:
  • 资助金额:
    $20.83万
  • 财政年份:
    1997
  • 负责人:
    EDWARD B LEOF
  • 依托单位:
TGF BETA RECEPTOR DYNAMICS
  • 批准号:
    2701838
  • 项目类别:
  • 资助金额:
    $21.45万
  • 财政年份:
    1997
  • 负责人:
    EDWARD B LEOF
  • 依托单位:
海外基金